| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Pathology, University of Edinburgh, Scotland, and Division of Parasitology, National Institute for Medical Research, London, England
Abstract
The capacity of human eosinophils, neutrophils, and mononuclear leukocytes to damage schistosomula coated with antibody and/or complement has been studied by using an in vitro assay in which helminth destruction was visualised directly. Schistosomula and leukocytes were incubated either with i) antibody (Ab) alone (as baboon anti-schistosomula serum, or serum from patients with schistosomiasis or its IgG fraction); ii) complement (C) alone (by incubating schistosomula with fresh serum that led to activation by the tegument of the alternate pathway of complement as shown by immunofluorescence with anti-C3, but not anti-C4, both with normal and C2-deficient serum); or iii) the combination of Ab and C.
The efficiency of killing of schistosomula by granulocytes (i.e., mixtures of eosinophils and neutrophils) was 31 ± 7% for Ab alone, 52 ± 9% for C alone, and 70 ± 8% for Ab + C; control preparations were approximately 14%. Equivalent numbers of mononuclear leukocytes gave 22 ± 3%, 31 ± 5%, and 37 ± 4% killing with Ab alone, C alone, or Ab + C, respectively.
Schistosomula killing was directly related to the concentration of antibody with Ab alone and to the dilution of complement with C alone and Ab + C. Damage by granulocytes or mononuclear leukocytes was dependent on the ratio of effector cells to schistosomula in the three experimental systems.
Granulocyte-dependent damage was enhanced by the sequential addition, to schistosomula sensitized with antibody, of purified components of the classical pathway of complement and was directly related to the input of C3. This observation, together with the direct visualisation of C3 by immunofluorescence, suggests the participation of the classical pathway of complement in the Ab + C system.
Footnotes
1 This work was supported by the Medical Research Council (United Kingdom).
2 Dr. Anwar is a British Council Fellow.
3 Address correspondence to: Dr. A. B. Kay, Department of Pathology, University Medical School, Teviot Place, Edinburgh, EH8 9AG, Scotland, United Kingdom.
This article has been cited by other articles:
|
|
 |
|
  L. A. Kerepesi, J. A. Hess, T. J. Nolan, G. A. Schad, and D. Abraham Complement Component C3 Is Required for Protective Innate and Adaptive Immunity to Larval Strongyloides stercoralis in Mice J. Immunol., April 1, 2006; 176(7): 4315 - 4322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Ligas, L. A. Kerepesi, A. M. Galioto, S. Lustigman, T. J. Nolan, G. A. Schad, and D. Abraham Specificity and Mechanism of Immunoglobulin M (IgM)- and IgG-Dependent Protective Immunity to Larval Strongyloides stercoralis in Mice Infect. Immun., December 1, 2003; 71(12): 6835 - 6843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Cormier, S. Yuan, J. R. Crosby, C. A. Protheroe, D. M. Dimina, E. M. Hines, N. A. Lee, and J. J. Lee TH2-Mediated Pulmonary Inflammation Leads to the Differential Expression of Ribonuclease Genes by Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 678 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Capron, J. Dessaint, M Capron, J. Ouma, and A. Butterworth Immunity to schistosomes: progress toward vaccine Science, November 20, 1987; 238(4830): 1065 - 1072. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
